-
公开(公告)号:EP3189078B1
公开(公告)日:2020-11-04
申请号:EP15748040.1
申请日:2015-08-10
申请人: International-Drug-Development-Biotech , Université Claude Bernard Lyon 1 , Hospices Civils De Lyon , Centre National de la Recherche Scientifique (C.N.R.S.) , Institut National de la Santé et de la Recherche Médicale (INSERM) , Centre de Lutte Contre le Cancer Léon Bérard
-
公开(公告)号:EP3189078A1
公开(公告)日:2017-07-12
申请号:EP15748040.1
申请日:2015-08-10
申请人: International-Drug-Development-Biotech , Université Claude Bernard Lyon 1 , Hospices Civils De Lyon , Centre National de la Recherche Scientifique (C.N.R.S.) , Institut National de la Santé et de la Recherche Médicale (INSERM) , Centre de Lutte Contre le Cancer Léon Bérard
发明人: ALBARET, Marie, Alexandra , DIAZ, Jean-Jacques , MERTANI, Hichem, Claude , SAURIN, Jean-Christophe , VERMOT-DESROCHES, Claudine , VUILLERMOZ, Boris
摘要: The present disclosure relates to a human CK8 antigen peptide, an antibody, or antibody fragment thereof, or a humanized antibody, specifically binding the peptide having the amino acid sequence of SEQ ID No. 29, a fragment of CK-8. Said molecules can be used use in the detection and/or treatment of tumors whose cells express CK8 protein, in particular the peptide of sequence according to SEQ ID No.29, on their surface.
摘要翻译: 本公开涉及特异性结合具有SEQ ID No.29的氨基酸序列的肽(CK-8的片段)的人CK8抗原肽,抗体或其抗体片段或人源化抗体。 所述分子可用于在其表面上检测和/或治疗其细胞表达CK8蛋白的肿瘤,特别是根据SEQ ID No.29的序列的肽。
-